Therefore, in order to aid the design of rational, targeted, anti-fibrotic therapies to treat patients with skeletal muscle or cardiac fibrosis, we used Pdgfrb-Cre to help identify the key molecular mechanisms driving muscle fibrosis. Here, PDGFRB is linked to fibrosis.